Език: EN EN
← Назад към резултатите
Набира участници Не е приложимо NCT07045259

Effect of Exergaming Program Versus Neuromuscular Exercise in Elderly People With Motor Cognitive Risk Syndrome

Не е приложима фаза (напр. обсервационно)
Заболявания: Motoric Cognitive Risk Syndrome Elderly (People Aged 65 or More) Geriatric Patient Exergaming Neuromuscular Exercise

Спонсор: Istanbul University - Cerrahpasa

Налично на: БГ
Обобщение
The primary aim of our study is to compare the effects of neuromuscular exercise training versus structured exergaming program on locomotor and cognitive functions in elderly individuals with Motor Cognitive Risk (MCR), which defines the transition state between typical aging and dementia and mild cognitive impairment. This study aims to present for the first time the effects of neuromuscular exercise training and exergaming program on locomotor and cognitive functions in elderly individuals with MCR with comparative results.
Кой може да участва
Inclusion Criteria: * Being over 65 years of age * Having a Barthel Daily Living Activities Index score of ≥ 90 * Having a Mini Mental Status Score (MMSE) of ≥24 * Having the ability to walk with or without a walking aid * Having a slow walking speed * Having subjective memory complaints Exclusion Criteria: * Presence of Dementia * Major Depression * Generalized Anxiety Disorder and Delirium * Parkinson's Disease * Anemia * Thyroid Disease * Vitamin B12 Deficiency * Malnutrition * Terminal Illness * Hearing or Visual Impairment
Интервенции
The Neuromuscular Exercise Training program
OTHER
Exergaming Exercise Training
OTHER
Места на провеждане 1
Турция (1)
Balıkesir Üniversitesi
Balıkesir
GULFİDAN TOKGÖZ, Lecturer, PhD (c)
Технически детайли
Статус
Набира участници
Фаза
Не е приложимо
Вид изследване
INTERVENTIONAL
Пол
Мъже и жени
Минимална възраст
65 Years
Здрави доброволци
Не
Начална дата
25.12.2025
Крайна дата
30.06.2026
Регистрационен номер
NCT07045259
Източник
clinicaltrials.gov
Запитване за медицински туризъм

Информацията е извлечена автоматично от ClinicalTrials.gov. Консултирайте се с вашия лекар преди да предприемете действия.